日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The microbiome in cancer

癌症中的微生物组

Lin, Anqi; Xiong, Minying; Jiang, Aimin; Huang, Lihaoyun; Wong, Hank Z H; Feng, Suyin; Zhang, Chunyan; Li, Yu; Chen, Li; Chi, Hao; Zhang, Pengpeng; Ye, Bicheng; Zhang, Hengguo; Zhang, Nan; Zhu, Lingxuan; Mou, Weiming; Shen, Junyi; Li, Kailai; Xu, Wentao; Ying, Haoxuan; Zhang, Cangang; Zeng, Dongqiang; Xie, Jindong; Deng, Xinpei; Wang, Qi; Xu, Jianying; Shi, Wenjie; Qi, Chang; Qu, Chunrun; Huang, Xufeng; Hajdu, András; Li, Chaoqun; Peng, Changmin; Cao, Xuanye; Pei, Guangsheng; Zhang, Lin; Huo, Yujia; Xu, Jiabao; Glaviano, Antonino; Szöllősi, Attila Gábor; Bian, Sicheng; Li, Zhengrui; Tang, Hailin; Tang, Bufu; Liu, Zaoqu; Zhang, Jian; Miao, Kai; Cheng, Quan; Wei, Ting; Yuan, Shuofeng; Luo, Peng

Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti-PD-L1 Immunotherapy

靶向PFKFB4的仿生共递送系统可协同增强铁死亡,从而抑制小细胞肺癌并提高抗PD-L1免疫疗法的疗效。

Liu, Xiang; He, Jingjun; Ying, Haoxuan; Chen, Cuiying; Zheng, Chongyang; Luo, Peng; Zhu, Weiliang; Wei, Ting; Tang, Bufu; Zhang, Jian

THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research

THER:用于肿瘤乏氧探索和研究的综合性网络工具

Zhang, Yasi; Liu, Huiying; Zhang, Pengpeng; Ye, BiCheng; Ying, Haoxuan; Yang, Hong; Zhang, Jian; Zhang, Nan; Li, Kailai; Wei, Ting; Jiang, Aimin; Lin, Anqi; Luo, Peng

Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validation

基于整合机器学习的肺癌化疗敏感性预测方法:从算法到细胞系验证

Chen, Jinghong; Yi, Yonglin; Yang, Chunqian; Ying, Haoxuan; Zhang, Jian; Lin, Anqi; Wei, Ting; Luo, Peng

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung Cancer.

HDAC抑制剂可激活肿瘤可塑性,增强Myc驱动的小细胞肺癌的免疫治疗反应。

Ghafoor Azam, Zhu Linying, Ohler Zoe Weaver, Meskini Rajaa El, Atkinson Devon, Day Amanda, Bassel Laura, Wang Weixin, Ying Haoxuan, Calvo Katherine R, Pongor Lorinc, Pommier Yves, Thomas Anish, Sun Yilun

Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non-inflamed tumour microenvironment in nasopharyngeal carcinoma

同源重组缺陷(HRD)与鼻咽癌预后良好相关,并可能导致肿瘤微环境无炎症反应。

Zhou, Xinyi; Ying, Haoxuan; Sun, Yujie; Zhang, Wenda; Luo, Peng; Zhu, Shuhan; Zhang, Jian

Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma.

基于恶性细胞相关配体受体基因的多组学鉴定肺腺癌特征

Xu Shengshan, Chen Xiguang, Ying Haoxuan, Chen Jiarong, Ye Min, Lin Zhichao, Zhang Xin, Shen Tao, Li Zumei, Zheng Youbin, Zhang Dongxi, Ke Yongwen, Chen Zhuowen, Lu Zhuming

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

MHC-II 特征与抗肿瘤免疫相关,并可预测膀胱癌抗 PD-L1 治疗反应

Yi, Ruibin; Hong, Shuo; Zhang, Yueming; Lin, Anqi; Ying, Haoxuan; Zou, Weidong; Wang, Qiongyao; Wei, Ting; Cheng, Quan; Zhu, Weiliang; Luo, Peng; Zhang, Jian